ALL ABOUT HEALTH -

07Feb 2023 by Janice Holland

High Intensity Exercise May Reduce the Risk of Metastatic Cancer

Main

Aerobic exercise may reduce the risk of metastatic cancer by 72 percent, according to new research published in the November 15 issue of Cancer Research. The study is the first to investigate the impact of exercise on the internal organs in which metastases usually develop, like the lungs, liver, and lymph nodes.The findings suggest that high-intensity aerobic exercise, which derives its energy from sugar, can reduce the risk of metastatic cancer, said research leaders Carmit Levy, PhD, and Yftach Gepner, PhD, in a press release. “If so far the general message to the public has been 'be active, be healthy', now we can explain how aerobic activity can maximize the prevention of the most aggressive and metastatic types of cancer,” the authors said.Physical Activity and Cancer RiskThe evidence suggesting that higher physical…

07Feb 2023 by Janice Holland

More Teens Are Vaping Within 5 Minutes of Waking

Main

Between 2014 and 2021, U.S. middle and high school students began vaping at an earlier age, with use among young people peaking in 2019. Although the number of teens using e-cigarettes has declined slightly since then, daily frequency of vaping and the number of teens using a tobacco product within the first five minutes of waking up are both on the rise, according to a new analysis published November 7 in JAMA Network Open.These findings may reflect the increasing use of nicotine for self-medication in response to adolescent depression, anxiety, tic disorders, and suicidality that rose during the COVID-19 pandemic, the researchers wrote.“The increasing intensity of use of modern e-cigarettes highlights the clinical need to address youth addiction to these new high nicotine products over the course of many clinical encounters,”…

07Feb 2023 by Janice Holland

Tyson Ground Beef Recalled Due to ‘Possible Foreign Matter Contamination’

Main

Tyson Fresh Meats is recalling approximately 93,697 pounds of raw ground beef products that may be contaminated with foreign objects, according to the U.S. Department of Agriculture (USDA) Food Safety and Inspection Service (FSIS).The recall was issued after the company received customer complaints about finding “mirror-like” material in ground beef purchased at grocery stores in Texas, where Tyson is based, FSIS said in a statement.“There have been no confirmed reports of adverse reactions due to consumption of these products,” FSIS said. “Anyone concerned about an injury or illness should contact a healthcare provider.”This will go down as one of the biggest beef recalls in U.S. history. At least two recalls were larger, according to the USDA — one involving 143,000 pounds (PDF) of meat produced by Westland-Hallmark Meat Company that…

07Feb 2023 by Janice Holland

RSV Is Hospitalizing Seniors at an Abnormally High Rate

Main

Cases of RSV (respiratory syncytial virus) and other respiratory illnesses have been surging throughout the United States. While recent headlines have been focusing on how children infected with RSV have been filling hospitals to capacity, older adults are also being hospitalized at a rate that is unusually high compared with previous years.Latest data (as of the week ending November 5) from the Centers for Disease Control and Prevention (CDC) shows that seniors ages 65 and up with RSV are filling hospital beds at a weekly rate of 1.6 per 100,000. Since the 2014–2015 season, CDC figures show that this hospitalization rate had not risen above 1 per 100,000. In 2018 at this same time of year, seniors with RSV were being admitted to the hospital at a low 0.2 per 100,000…

07Feb 2023 by Janice Holland

FDA Approves First Drug to Delay Onset of Type 1 Diabetes

Main

For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug that can delay the development of type 1 diabetes.The intravenous drug, teplizumab-mzwv (Tzield), is for adults and children 8 years and older who are at high risk for type 1 diabetes but haven’t yet been diagnosed with the condition and have not yet become reliant on insulin shots. Tzield is in a new family of medicines that slow the immune system’s attack on insulin-producing cells in the pancreas, which is the underlying cause of type 1 diabetes.“Today’s approval of a first-in-class therapy adds an important new treatment option for certain at-risk patients,” said John Sharretts, MD, the director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and…

07Feb 2023 by Janice Holland

Experts Debunk Myths About Alternative Medicine for Heart Disease, Heart Failure

Main

Now more than ever, people are turning to home remedies like herbal medicines, dietary supplements, and homeopathic products, and activities such as yoga, massage therapy, and acupuncture to treat what ails them. The alternative medicine market reached $100 billion in 2021 and projections show that value more than tripling in the next five years, according to a 2022 report from Research and Markets.The use of alternative medicines was a topic of discussion at a panel held on Sunday, November 6 at the AHA Scientific Sessions 2022. Experts addressed myths related to alternative medicines in people with heart disease, such as heart failure. Want to know what the experts think about alternative medicine? Here’s a rundown of what they discussed.Don’t Place Alternative Therapy Above Traditional Medicine“It's critical for us to educate…

06Feb 2023 by Janice Holland

FDA Gives First-Ever Approval for Fecal Transplant Therapy

Main

The U.S. Food and Drug Administration (FDA) has approved a fecal transplant therapy to prevent recurrence of a bacterial infection that kills up to 30,000 people a year.The therapy, Rebyota, is the first fecal transplant product approved in the United States, the FDA said in a statement. It’s cleared to combat Clostridioides difficile, or C. difficile, a bacteria that can flourish in the gut and cause diarrhea, abdominal pain, and fever, and in rare cases leads to organ failure and death.“Recurrent Clostridioides difficile infection impacts an individual’s quality of life and can also potentially be life-threatening,” said Peter Marks, MD, PhD, the director of the FDA’s Center for Biologics Evaluation and Research, in a statement. The approval of Rebyota “represents an important milestone, as it provides an additional approved option to…

06Feb 2023 by Janice Holland

Blood Pressure Pills Recalled Over Potential Cancer Risk

Main

Editor’‎s NoteThis story was originally published on Oct. 28, 2022.On Dec. 21, 2022, the FDA announced another distributor, Lupin Pharmaceuticals, was also recalling four lots of the blood pressure medication quinapril for excessive nitrosamines. Source link

06Feb 2023 by Janice Holland

High Blood Pressure Medicine Recalled Again Due to Possible Cancer Risk

Main

Four lots of the generic high blood pressure medication quinapril tablets have been recalled by its manufacturer, Lupin Pharmaceuticals, because of abnormally high amounts of a probable cancer-causing impurity.Recent testing revealed levels of a nitrosamine impurity (N-nitroso-quinapril) were above the U.S. Food and Drug Administration's (FDA) acceptable daily intake level.While long-term ingestion of this suspected carcinogen may increase cancer risk, there is no immediate danger to patients taking this medication.According to an announcement from the FDA issued on December 21, the quinapril products in question are:20 mg tablets, lot number G102929, expiration date 04/202340 mg tablets, lot number G100533, expiration date 12/202240 mg tablets, lot number G100534, expiration date 12/202240 mg tablets, lot number G203071, expiration date 03/2024The pills were packaged in 90-count bottles and distributed nationwide to wholesalers, drug chains, mail…

06Feb 2023 by Janice Holland

FDA Says Morning-After Pill Isn’t Abortion

Main

The U.S. Food and Drug Administration (FDA) is changing the packaging information for the emergency contraception pill Plan B to explicitly state a fact that has long been well understood in the medical community: This drug can prevent pregnancy but can’t cause an abortion.Plan B is approved for women to take within 72 hours of sex to prevent pregnancy, and is available over the counter without a prescription or medical exam. The FDA is revising labels inside the package for Plan B to remove a statement unsupported by scientific evidence: that this drug might stop a fertilized egg from implanting in the uterus.Changes to the packaging labels for Plan B clearly distinguish this form of contraception from medication abortion pills, which can stop a pregnancy after a fertilized egg is…